Contract Research & Services
Contract Research

Contract Research News

View news from other Pharmaceutical sectors:
61-75 of 2114 results
Kite Pharma, Cell Design Labs collaborate on new CAR T-Cell immunotherapies
By PBR Staff Writer
Kite Pharma and Cell Design Labs have announced a research collaboration and license agreement to develop new CAR T-Cell immunotherapies.
Contract Research & Services > Contract Research > News
Sanofi Genzyme forms multiple sclerosis research collaboration with Johns Hopkins School of Medicine
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced a research collaboration with the Johns Hopkins School of Medicine that will focus on novel strategies aimed at advancing the understanding of underlying causes of disease progression in multiple sclerosis (MS).
Contract Research & Services > Contract Research > News
HTG Molecular Diagnostics signs immuno-oncology research collaboration deal with Bristol-Myers Squibb
HTG Molecular Diagnostics has formed a research collaboration agreement with Bristol-Myers Squibb to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types.
Contract Research & Services > Contract Research > News
Seres Therapeutics forms research collaboration with Memorial Sloan Kettering Cancer Center
Seres Therapeutics, a microbiome therapeutics platform company, today announced that it has entered into a strategic, multi-year research collaboration with Memorial Sloan Kettering Cancer Center (MSK).
Contract Research & Services > Contract Research > News
Biosortia Pharmaceuticals launches three new oncology research projects
By PBR Staff Writer
Biosortia Pharmaceuticals has launched three new oncology research projects using microbial compounds.
Contract Research & Services > Contract Research > News
BIND Therapeutics forms Accurins development collaboration with Affilogic
BIND Therapeutics has entered into a research collaboration with privately-held biotechnology firm Affilogic, a developer of affinity proteins dubbed Nanofitins that selectively bind to specific targets.
Contract Research & Services > Contract Research > News
Researchers find new treatment for lethal resistant prostate cancers
Researchers from the Institute of Cancer Research (ICR), London, have said that a new type of drug could benefit men with aggressive prostate cancer that has stopped responding to treatment.
Contract Research & Services > Contract Research > News
AbbVie forms two oncology-focused collaborations with CytomX and argenx
By PBR Staff Writer
Research-based biopharmaceutical firm AbbVie has entered into two oncology-focused collaborations with CytomX Therapeutics and argenx.
Contract Research & Services > Contract Research > News
Basilea signs deal with BARDA for phase 3 development of ceftobiprole antibiotic
By PBR Staff Writer
Basilea Pharmaceutica has signed an agreement worth $100m with the US Department of Health for the clinical phase 3 development of ceftobiprole antibiotic.
Contract Research & Services > Contract Research > News
Astex, Genentech partner to explore combination treatment for acute myeloid leukemia
By PBR Staff Writer
Astex Pharmaceuticals has formed a clinical trial collaboration with Genentech to explore a combination treatment for acute myeloid leukemia (AML).
Contract Research & Services > Contract Research > News
Compugen achieves preclinical milestone in cancer immunotherapy collaboration with Bayer
Compugen has achieved a first preclinical milestone for CGEN-15022 pursuant to its cancer immunotherapy collaboration with Bayer.
Contract Research & Services > Contract Research > News
Presage Biosciences extends research collaboration with Takeda to discover novel cancer drug combinations
Presage Biosciences has entered into a multi-year extension of its November 2014 research alliance with Takeda Pharmaceuticals Company.
Contract Research & Services > Contract Research > News
PsiOxus, Parker Institute for Cancer Immunotherapy plan to partner on tumor-specific immuno-gene therapy
PsiOxus Therapeutics and the newly launched Parker Institute for Cancer Immunotherapy have signed a Memorandum of Understanding (MoU) for a planned collaboration using the Tumor-Specific Immuno-Gene Therapy (T-SIGn) platform developed by PsiOxus.
Contract Research & Services > Contract Research > News
Allergan partners with Heptares to develop treatments for neurological disorders
By PBR Staff Writer
Allergan and Heptares Therapeutics have formed a global R&D and commercialization partnership for novel treatments in Alzheimer's and other neurological disorders.
Contract Research & Services > Contract Research > News
Forge Therapeutics and Active Motif form epigenetics research collaboration
By PBR Staff Writer
Forge Therapeutics and Active Motif said they will collaborate on epigenetic research related to the family of iron-containing lysine demethylases known as Jumonji KDMs.
Contract Research & Services > Contract Research > News
61-75 of 2114 results